Published in Blood on May 15, 1990
Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells. Proc Natl Acad Sci U S A (2006) 3.73
Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival. Cancer Res (2011) 2.50
ALDH1 expression correlates with favorable prognosis in ovarian cancers. Mod Pathol (2009) 1.70
Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression. Neoplasia (2009) 1.60
Achaete-scute complex homologue 1 regulates tumor-initiating capacity in human small cell lung cancer. Cancer Res (2009) 1.55
Aldehyde dehydrogenase activity as a functional marker for lung cancer. Chem Biol Interact (2008) 1.52
Cancer stem cells in lung cancer: Evidence and controversies. Respirology (2013) 1.46
Differentiation of a highly tumorigenic basal cell compartment in urothelial carcinoma. Stem Cells (2009) 1.30
The biology of head and neck cancer stem cells. Oral Oncol (2011) 1.25
In search of "stemness". Exp Hematol (2004) 1.21
DNER, an epigenetically modulated gene, regulates glioblastoma-derived neurosphere cell differentiation and tumor propagation. Stem Cells (2009) 1.20
High aldehyde dehydrogenase activity identifies cancer stem cells in human cervical cancer. Oncotarget (2013) 1.15
Rebooting the immune system with high-dose cyclophosphamide for treatment of refractory myasthenia gravis. Ann N Y Acad Sci (2008) 1.10
Aldehyde dehydrogenases: from eye crystallins to metabolic disease and cancer stem cells. Chem Biol Interact (2012) 1.10
Cancer vaccines targeting the epithelial-mesenchymal transition: tissue distribution of brachyury and other drivers of the mesenchymal-like phenotype of carcinomas. Semin Oncol (2012) 1.10
Cancer stem cells, cancer cell plasticity and radiation therapy. Semin Cancer Biol (2014) 1.08
Self-renewal of acute lymphocytic leukemia cells is limited by the Hedgehog pathway inhibitors cyclopamine and IPI-926. PLoS One (2010) 1.06
Cancer stem cells in multiple myeloma. Cancer Lett (2008) 1.06
Aldehyde dehydrogenase 1A1 in stem cells and cancer. Oncotarget (2016) 1.06
New insights into prostate cancer stem cells. Cell Cycle (2013) 1.02
Aldehyde dehydrogenase 1A1--a new mediator of resistance to temozolomide in glioblastoma. Neuro Oncol (2012) 0.98
T-cell replete haploidentical donor transplantation using post-transplant CY: an emerging standard-of-care option for patients who lack an HLA-identical sibling donor. Bone Marrow Transplant (2014) 0.97
NOTCH-induced aldehyde dehydrogenase 1A1 deacetylation promotes breast cancer stem cells. J Clin Invest (2014) 0.97
Identification of an ABCB1 (P-glycoprotein)-positive carfilzomib-resistant myeloma subpopulation by the pluripotent stem cell fluorescent dye CDy1. Am J Hematol (2013) 0.96
Interplay of Stem Cell Characteristics, EMT, and Microtentacles in Circulating Breast Tumor Cells. Cancers (Basel) (2013) 0.94
Intensive immunosuppression with high dose cyclophosphamide but without stem cell rescue for severe autoimmunity: advantages and disadvantages. Autoimmunity (2008) 0.93
Stem cell origins of leukaemia and curability. Br J Cancer (1993) 0.92
High-dose cyclophosphamide without stem cell rescue in 207 patients with aplastic anemia and other autoimmune diseases. Medicine (Baltimore) (2011) 0.91
Stem cells, phenotypic inversion, and differentiation. Int J Clin Exp Med (2008) 0.91
Aldehyde dehydrogenase activity identifies a population of human skeletal muscle cells with high myogenic capacities. Mol Ther (2009) 0.90
Aldehyde dehydrogenase 3A1 associates with prostate tumorigenesis. Br J Cancer (2014) 0.87
N,N-diethylaminobenzaldehyde (DEAB) as a substrate and mechanism-based inhibitor for human ALDH isoenzymes. Chem Biol Interact (2014) 0.86
Multi-parameter fluorescence-activated cell sorting and analysis of stem and progenitor cells in myeloid malignancies. Best Pract Res Clin Haematol (2010) 0.86
ALDH1 immunohistochemical expression and its significance in salivary adenoid cystic carcinoma. Head Neck (2012) 0.86
Urothelial carcinoma: stem cells on the edge. Cancer Metastasis Rev (2009) 0.86
Normal hematopoietic stem cells within the AML bone marrow have a distinct and higher ALDH activity level than co-existing leukemic stem cells. PLoS One (2013) 0.85
Identification and targeting leukemia stem cells: The path to the cure for acute myeloid leukemia. World J Stem Cells (2014) 0.85
4-(N,N-dipropylamino)benzaldehyde inhibits the oxidation of all-trans retinal to all-trans retinoic acid by ALDH1A1, but not the differentiation of HL-60 promyelocytic leukemia cells exposed to all-trans retinal. BMC Pharmacol (2002) 0.84
Cord blood-derived hematopoietic stem/progenitor cells: current challenges in engraftment, infection, and ex vivo expansion. Stem Cells Int (2011) 0.83
Stem-like cells and therapy resistance in squamous cell carcinomas. Adv Pharmacol (2012) 0.83
Whole-mount fluorescent in situ hybridization staining of the colonial tunicate Botryllus schlosseri. Genesis (2014) 0.82
Cancer stem cell-related marker expression in lung adenocarcinoma and relevance of histologic subtypes based on IASLC/ATS/ERS classification. Onco Targets Ther (2013) 0.82
Development of a high-throughput in vitro assay to identify selective inhibitors for human ALDH1A1. Chem Biol Interact (2014) 0.82
Lights and shadows of cyclophosphamide in the treatment of multiple sclerosis. Autoimmune Dis (2011) 0.81
A retrospective review of the prognostic value of ALDH-1, Bmi-1 and Nanog stem cell markers in esophageal squamous cell carcinoma. PLoS One (2014) 0.81
Lung cancer-initiating cells: a novel target for cancer therapy. Target Oncol (2013) 0.80
Transcriptional Regulation of Aldehyde Dehydrogenase 1A1 Gene by Alternative Spliced Forms of Nuclear Factor Y in Tumorigenic Population of Endometrial Adenocarcinoma. Genes Cancer (2011) 0.80
Targeting cancer stem cells by using the nanoparticles. Int J Nanomedicine (2015) 0.79
Identification of tumor endothelial cells with high aldehyde dehydrogenase activity and a highly angiogenic phenotype. PLoS One (2014) 0.79
Haploidentical bone marrow and stem cell transplantation: experience with post-transplantation cyclophosphamide. Semin Hematol (2016) 0.79
Hematopoietic stem cells. Methods Enzymol (2006) 0.78
Stem-like features of cancer cells on their way to metastasis. Biol Direct (2016) 0.78
Haploidentical Hematopoietic Stem Cell Transplantation as a Platform for Post-Transplantation Cellular Therapy. Biol Blood Marrow Transplant (2015) 0.78
A phase i study of DMS612, a novel bifunctional alkylating agent. Clin Cancer Res (2014) 0.78
High-dose cyclophosphamide without stem cell rescue for the treatment of refractory Behcet's disease. Semin Arthritis Rheum (2011) 0.78
Characterization of cardiac-resident progenitor cells expressing high aldehyde dehydrogenase activity. Biomed Res Int (2013) 0.77
9-O-acetylated sialic acids differentiating normal haematopoietic precursors from leukemic stem cells with high aldehyde dehydrogenase activity in children with acute lymphoblastic leukaemia. Glycoconj J (2014) 0.77
Flow cytometric detection of the classical hodgkin lymphoma: clinical and research applications. Adv Hematol (2010) 0.77
Clinicopathological significance of cancer stem-like cell markers in high-grade neuroendocrine carcinoma of the lung. J Cancer Res Clin Oncol (2015) 0.76
Development and validation of a rapid, aldehyde dehydrogenase bright-based cord blood potency assay. Blood (2016) 0.76
Temporally and spatially dynamic germ cell niches in Botryllus schlosseri revealed by expression of a TGF-beta family ligand and vasa. Evodevo (2016) 0.75
Aldehyde dehydrogenase is used by cancer cells for energy metabolism. Exp Mol Med (2016) 0.75
Evaluation of posttransplant methotrexate to facilitate engraftment in the canine major histocompatibility complex-haploidentical nonmyeloablative transplant model. Transplantation (2010) 0.75
High-dose Cyclophosphamide is Effective Therapy for Pediatric Severe Aplastic Anemia. J Pediatr Hematol Oncol (2016) 0.75
Tumor-Initiating Cells: Emerging Biophysical Methods of Isolation. Curr Stem Cell Rep (2016) 0.75
Aldehyde dehydrogenase activity plays a Key role in the aggressive phenotype of neuroblastoma. BMC Cancer (2016) 0.75
Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen. Transplantation (2016) 0.75
Bladder cancer stem cells: clonal origin and therapeutic perspectives. Oncotarget (2017) 0.75
Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med (2000) 7.79
The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol (1986) 5.27
The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nat Genet (1996) 4.59
Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol (1984) 4.55
CD34: structure, biology, and clinical utility. Blood (1996) 4.41
Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. Proc Natl Acad Sci U S A (1999) 3.91
A novel temporal expression pattern of three C/EBP family members in differentiating myelomonocytic cells. Blood (1992) 3.18
Assessment of aldehyde dehydrogenase in viable cells. Blood (1995) 2.77
The patient-provider relationship: attachment theory and adherence to treatment in diabetes. Am J Psychiatry (2001) 2.57
DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma. J Clin Oncol (1998) 2.39
Home birth in New Zealand 1973-93: incidence and mortality. N Z Med J (1997) 2.38
Crystal structure of DMSO reductase: redox-linked changes in molybdopterin coordination. Science (1996) 2.35
Thalidomide for the treatment of chronic graft-versus-host disease. N Engl J Med (1992) 2.31
Irinotecan therapy in adults with recurrent or progressive malignant glioma. J Clin Oncol (1999) 2.23
Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release. Cancer Res (2000) 2.17
Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development. Blood (1987) 2.15
Psychiatric illness in patients with chronic fatigue and those with rheumatoid arthritis. J Gen Intern Med (1991) 2.13
Ifosfamide: should the honeymoon be over? J Clin Oncol (1995) 2.13
Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies. Cancer Res (1997) 2.12
Minimal anatomical disruption in stoma formation: the lateral rectus abdominis positioned stoma (LRAPS). Colorectal Dis (2010) 2.09
Relapse of depression in primary care. Rate and clinical predictors. Arch Fam Med (1998) 1.87
Experimental chemotherapy of human medulloblastoma cell lines and transplantable xenografts with bifunctional alkylating agents. Cancer Res (1988) 1.86
Can enhanced acute-phase treatment of depression improve long-term outcomes? A report of randomized trials in primary care. Am J Psychiatry (1999) 1.77
Characterization of mouse lymphohematopoietic stem cells lacking spleen colony-forming activity. Blood (1996) 1.76
Expression of the hematopoietic growth factor receptor FLT3 (STK-1/Flk2) in human leukemias. Blood (1996) 1.70
Carrier detection in X-linked agammaglobulinemia by analysis of X-chromosome inactivation. N Engl J Med (1987) 1.63
Flow cytometric analysis of human bone marrow: I. Normal erythroid development. Blood (1987) 1.60
Graft-versus-myeloma effect: proof of principle. Blood (1996) 1.58
Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation. Cancer Chemother Pharmacol (1989) 1.57
Inhibition of mouse cytosolic aldehyde dehydrogenase by 4-(diethylamino)benzaldehyde. Biochem Pharmacol (1988) 1.56
The estrogen receptor CpG island is methylated in most hematopoietic neoplasms. Cancer Res (1996) 1.56
Frequent detection of tumor cells in hematopoietic grafts in neuroblastoma and Ewing's sarcoma. Bone Marrow Transplant (1998) 1.51
Comparison of culture and microscopy in the diagnosis of Gardnerella vaginalis infection. J Clin Pathol (1982) 1.50
APOE related alterations in cerebral activation even at college age. J Neurol Neurosurg Psychiatry (2005) 1.49
Ablation of renal tumors in a rabbit model with interstitial saline-augmented radiofrequency energy: preliminary report of a new technology. Urology (1999) 1.49
Levels of p53 protein increase with maturation in human hematopoietic cells. Cancer Res (1991) 1.49
Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: the significance of the stem-cell glycoprotein CD34 (My10) Br J Haematol (1990) 1.45
Pharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain. Cancer Res (1998) 1.43
Characterization of cytosolic aldehyde dehydrogenase from cyclophosphamide resistant L1210 cells. Cancer Res (1988) 1.39
Role of aldehyde dehydrogenase in cyclophosphamide-resistant L1210 leukemia. Cancer Res (1984) 1.39
Depression, fatigue, and functional disability in patients with chronic hepatitis C. J Psychosom Res (2000) 1.32
Human AML cells in NOD/SCID mice: engraftment potential and gene expression. Leukemia (2002) 1.30
BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: a mechanism of resistance to multiple anticancer agents. Blood (1995) 1.30
Flow cytometric analysis of human bone marrow. IV. Differential quantitative expression of T-200 common leukocyte antigen during normal hemopoiesis. J Immunol (1988) 1.29
Methylator resistance mediated by mismatch repair deficiency in a glioblastoma multiforme xenograft. Cancer Res (1997) 1.24
Antigenic analysis of hematopoiesis. V. Characterization of My-10 antigen expression by normal lymphohematopoietic progenitor cells. Exp Hematol (1986) 1.24
My-1, the human myeloid-specific antigen detected by mouse monoclonal antibodies, is a sugar sequence found in lacto-N-fucopentaose III. Blood (1983) 1.23
Myeloid and megakaryocytic properties of K-562 cell lines. Cancer Res (1983) 1.23
The validity of verbal protocols. Mem Cognit (1989) 1.21
Altered cytoplasmic/nuclear distribution of the c-myc protein in differentiating ML-1 human myeloid leukemia cells. Cell Growth Differ (1993) 1.21
Purification of human erythroid colony-forming units and demonstration of specific binding of erythropoietin. J Clin Invest (1987) 1.21
Inhibition of FLT3-mediated transformation by use of a tyrosine kinase inhibitor. Leukemia (2001) 1.20
Antigenic analysis of hematopoiesis. VI. Flow cytometric characterization of My-10-positive progenitor cells in normal human bone marrow. Exp Hematol (1987) 1.19
Phase I trial of carmustine plus O6-benzylguanine for patients with recurrent or progressive malignant glioma. J Clin Oncol (2000) 1.19
Rapid detection of human infections with fluorine-18 fluorodeoxyglucose and positron emission tomography: preliminary results. Eur J Nucl Med (1998) 1.19
Characterization of melphalan-glutathione adducts whose formation is catalyzed by glutathione transferases. Biochem Pharmacol (1986) 1.19
Proceedings: Cyclophosphamide and the kidney. Cancer (1974) 1.18
Acute infectious mononucleosis: characteristics of patients who report failure to recover. Am J Med (2000) 1.18
The frequency of transcriptional and translational errors at nonsense codons in the lacZ gene of Escherichia coli. Mol Gen Genet (1983) 1.18
Eight lipooligosaccharides of Neisseria meningitidis react with a monoclonal antibody which binds lacto-N-neotetraose (Gal beta 1-4GlcNAc beta 1-3Gal beta 1-4Glc). Infect Immun (1991) 1.18
My-1, new myeloid-specific antigen identified by a mouse monoclonal antibody. Blood (1981) 1.17
Symptoms as a clue to otologic and psychiatric diagnosis in patients with dizziness. J Psychosom Res (1994) 1.17
Collaborative interventions for physically injured trauma survivors: a pilot randomized effectiveness trial. Gen Hosp Psychiatry (2001) 1.17
Further evaluation of the local lymph node assay in the final phase of an international collaborative trial. Toxicology (1996) 1.15
Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide. N Engl J Med (1986) 1.14
The intracerebral distribution of BCNU delivered by surgically implanted biodegradable polymers. J Neurosurg (1992) 1.13
High frequencies of leukemia stem cells in poor-outcome childhood precursor-B acute lymphoblastic leukemias. Leukemia (2010) 1.13
Purification of human blood burst-forming units-erythroid and demonstration of the evolution of erythropoietin receptors. J Cell Physiol (1990) 1.13
Junctional care: the key to prevention of catheter sepsis in intravenous feeding. JPEN J Parenter Enteral Nutr (1987) 1.11
Strategies for multiattribute binary choice. J Exp Psychol Learn Mem Cogn (1983) 1.10
Prospective study of the natural history of infectious mononucleosis caused by Epstein-Barr virus. J Am Board Fam Pract (2001) 1.08
Localization of hematopoietic progenitor cells in tissue with the anti-My-10 monoclonal antibody. Am J Pathol (1985) 1.08
Depression and self-reported physical health in patients with coronary disease: mediating and moderating factors. Psychosom Med (2001) 1.08
A structural basis for a phosphoramide mustard-induced DNA interstrand cross-link at 5'-d(GAC). Proc Natl Acad Sci U S A (1995) 1.07
Thymidine kinase activation of ganciclovir in recurrent malignant gliomas: a gene-marking and neuropathological study. J Neurosurg (2000) 1.06
Cyclophosphamide resistance in medulloblastoma. Cancer Res (1992) 1.06
Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma. Cancer Res (1994) 1.04
Distribution of the parathyroid hormone 2 receptor in rat: immunolocalization reveals expression by several endocrine cells. Endocrinology (1999) 1.04
Tnk1: a novel intracellular tyrosine kinase gene isolated from human umbilical cord blood CD34+/Lin-/CD38- stem/progenitor cells. Oncogene (1996) 1.03
Predictors and outcome of discharge against medical advice from the psychiatric units of a general hospital. Psychiatr Serv (1998) 1.03
Biology of CD34+CD38- cells in lymphohematopoiesis. Leuk Lymphoma (1998) 1.02
The role of aldehyde dehydrogenase isozymes in cellular resistance to the alkylating agent cyclophosphamide. Prog Clin Biol Res (1989) 1.02
Use of positron emission tomography to study AT1 receptor regulation in vivo. J Am Soc Nephrol (2001) 1.02
Antigenic analysis of hematopoiesis. IV. The My-11 hematopoietic cell surface antigen is expressed by myelomonocytic and lymphoid, but not erythroid, progenitor cells. Exp Hematol (1986) 1.00
Enhancement of irinotecan (CPT-11) activity against central nervous system tumor xenografts by alkylating agents. Cancer Chemother Pharmacol (1998) 1.00
Further characterization of immunological unresponsiveness induced in mice by ultraviolet radiation. Growth and induction of nonultraviolet-induced tumors in ultraviolet-irradiated mice. Transplantation (1979) 1.00
Induction of topoisomerase II activity after ErbB2 activation is associated with a differential response to breast cancer chemotherapy. Clin Cancer Res (2001) 0.99
Single cell origin of multilineage colonies in culture. Evidence that differentiation of multipotent progenitors and restriction of proliferative potential of monopotent progenitors are stochastic processes. J Clin Invest (1984) 0.99
Plasma pharmacokinetics and urinary excretion of thalidomide after oral dosing in healthy male volunteers. Drug Metab Dispos (1989) 0.99
Upper genital tract abnormalities and pregnancy outcome in diethylstilbestrol-exposed progeny. Am J Obstet Gynecol (1984) 0.99
Asynchronous antigen expression in B lineage acute lymphoblastic leukemia. Blood (1988) 0.99
Induction of phenobarbital of microsomal mixed oxidase enzymes in regenerating rat liver. J Biol Chem (1970) 0.98
Progenitor cell assays predict hematopoietic reconstitution after syngeneic transplantation in mice. Blood (1987) 0.98
New prodrug activation gene therapy for cancer using cytochrome P450 4B1 and 2-aminoanthracene/4-ipomeanol. Hum Gene Ther (1998) 0.97